Pfizer Inc. (PFE)

54.17
1.80 3.40
NYSE
Prev Close 52.40
Open 52.31
Day Low/High 51.91 / 54.46
52 Wk Low/High 33.36 / 55.70
Volume 64.26M
Exchange NYSE
Shares Outstanding 5612.87B
Market Cap 303.09B
P/E Ratio 23.58
Div & Yield N.A. (N.A)
Asia's Outbreaks Risk Renewed Infection, Economic Stagnation

Asia's Outbreaks Risk Renewed Infection, Economic Stagnation

Investors should watch Asian vaccination rates for a guide to the continent's economic rebound.

Pfizer Price Targets? I've Got Them for You

Pfizer Price Targets? I've Got Them for You

A subscriber asks. We answer.

China 'Rules', Defense Stocks, Infrastructure Package, FOMC, Earnings

China 'Rules', Defense Stocks, Infrastructure Package, FOMC, Earnings

What if Beijing plays the power game with foreign firms reliant upon Chinese revenue, Chinese labor, or simply Chinese economic growth?

The Week Ahead, Earnings, Macro, Virus, Monetary and Fiscal Policy, Trading Roku

The Week Ahead, Earnings, Macro, Virus, Monetary and Fiscal Policy, Trading Roku

This week will tax your brain. Your ability to focus on what really matters will be tested.

Jim Cramer: The Great American Snag

Jim Cramer: The Great American Snag

But remember I think it's all a snag and one that will be rectified in two ways.

Look for COVID Concerns to Continue to Drive Market Action

Look for COVID Concerns to Continue to Drive Market Action

It would not be surprising to see this seesaw action repeatedly in the months ahead.

Biden's Spending Plan, Market Rally, Trading Nvidia, Netflix, Chipotle

Biden's Spending Plan, Market Rally, Trading Nvidia, Netflix, Chipotle

Also, there's reason to turn J&J's one shot jab into a two shot vaccine just like the rest.

The Market's Current Mood Brings Back Memories of Late 2018

The Market's Current Mood Brings Back Memories of Late 2018

Just as fears of Fed tightening and a trade war created buying opportunities in tech and elsewhere in late 2018, arguably overblown fears about the Delta variant's economic impact are creating opportunities now.

Is Pfizer Ready to Make an Upside Breakout?

Is Pfizer Ready to Make an Upside Breakout?

Traders could go long PFE at current levels and here's where they can add to longs.

One Really Bad Dream (or Was It?), Biden Hops on the Rails, Vaccine Booster

One Really Bad Dream (or Was It?), Biden Hops on the Rails, Vaccine Booster

Plus, China's central bank plans to cut its Reserve Ratio Requirement and Wells Fargo looks to exit a business line.

Organized Chaos, Growth Concerns, COVID Variant, Trading Amazon and Microsoft

Organized Chaos, Growth Concerns, COVID Variant, Trading Amazon and Microsoft

Contrary to popular belief, this economic recovery that we seem to be enjoying has hit a pressure point.

Jim Cramer: Nasdaq's Big Second-Quarter Winners Were Written Off Too Soon

Jim Cramer: Nasdaq's Big Second-Quarter Winners Were Written Off Too Soon

These companies were counted out way too early in the post-pandemic environment and the sellers are experiencing some real regret.

Jim Cramer: Monday's Market Is One of the Most Mind-Blowing I've Seen

Jim Cramer: Monday's Market Is One of the Most Mind-Blowing I've Seen

Buyers make or break companies with their voting or buying or betting. Somedays it's all that matters.

Uncertain Fiscal Policy, FOMC, Virus X Factor, Copper, United Rentals Stock

Uncertain Fiscal Policy, FOMC, Virus X Factor, Copper, United Rentals Stock

There's a split growing at the FOMC as to just how transitory the current burst of consumer level inflation actually is.

The Fed Is Doing Exactly What They Said They'd Do

The Fed Is Doing Exactly What They Said They'd Do

Here's a challenge to the bond bear thesis.

GlaxoSmithKline Needs More Positive Developments Before Investing

GlaxoSmithKline Needs More Positive Developments Before Investing

Here's what Jim Cramer expects to hear from GSK at this week's investor meeting.

CureVac Is Down But Not Out: Here's How to Trade It

CureVac Is Down But Not Out: Here's How to Trade It

CVAC is now working on a 'next generation' COVID-19 vaccine candidate with GlaxoSmithKline.

Tech Rally, Acronym Animal Crackers, Fed, Dimon Hands, Trading Banks and SoFi

Tech Rally, Acronym Animal Crackers, Fed, Dimon Hands, Trading Banks and SoFi

The public seems to have resigned itself to dealing with a greater degree of inflation for longer than anything I would have considered to be 'transitory.' The again, the public is often as wrong as the Fed.

If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It

If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It

I prefer the bear put spread over the covered equity play due to the decreased risk to principal, despite the capped potential for profit.

Meme Focus, CPI, My Message to the Fed, Gensler to the Rescue? Likes/Dislikes

Meme Focus, CPI, My Message to the Fed, Gensler to the Rescue? Likes/Dislikes

How long have we cried out in the wilderness with no one listening? Finally, perhaps, a champion has risen from the depths.

Biogen's Japanese Partner on Alzheimer's Drug Set for Gains

Biogen's Japanese Partner on Alzheimer's Drug Set for Gains

Eisai is working on another promising drug candidate to combat Alzheimer's disease, and will benefit from a split of the profits for Aduhelm.

Auction Action

After a pretty solid two year note auction - tightly anchored by the fed funds rate expectations - today's 5 year was very good too. The yield of 0.788% was about ½ bp below the when issued. The bid to cover of 2.49 was better than the 12 month aver...

Are Chinese Shares Set for a Bull Run?

Are Chinese Shares Set for a Bull Run?

Last year's top-performing stock market worldwide has been a disappointment since setting an all-time high in February. Could it have just turned?

Jim Cramer: Disbelief in Science vs. COVID Shares Blame for Supply Shortages

Jim Cramer: Disbelief in Science vs. COVID Shares Blame for Supply Shortages

We've been caught with our pants down, largely because we had no faith in the smartest people in the country.

A Market Unmasked, Sectors Go Green, Treading Nasdaq Turf With Care

A Market Unmasked, Sectors Go Green, Treading Nasdaq Turf With Care

The market seems to rejoice from the latest mask utterance out of the CDC, but the action at the Nasdaq should give traders pause.

In the Midst of This Pandemic, Arcturus Therapeutics Has Its Lightbulb Moment

In the Midst of This Pandemic, Arcturus Therapeutics Has Its Lightbulb Moment

ARCT's IP is incredibly valuable, and may in fact be invaluable.

Thursday's Close Shave, Troubling New Highs and Lows, Peloton Kicks Into Gear

Thursday's Close Shave, Troubling New Highs and Lows, Peloton Kicks Into Gear

The market came within whiskers of a technical breakdown on Thursday, yet few people seem to know or care.

ARKK Under Pressure, Peloton, Vaccine Moral Dilemma, Charting the Nasdaq

ARKK Under Pressure, Peloton, Vaccine Moral Dilemma, Charting the Nasdaq

The fund is at a key spot technically, and there is real fear that if this spot cracks, what looks like a stretch of rough rapids could become a waterfall.

Invest in Pfizer? Know That the Stock Is Not Volatile or That Risky

Invest in Pfizer? Know That the Stock Is Not Volatile or That Risky

PFE reported Q1 earnings Tuesday and handily beat expectations.

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.